

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuronal action potential propagation (GO:0019227) | 5.07277313 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.99332593 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 4.87363597 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.83712592 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.82789765 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.80863558 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.75016068 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.65739047 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.65238817 |
| 10 | negative regulation of cell killing (GO:0031342) | 4.61487164 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.61487164 |
| 12 | synaptic vesicle maturation (GO:0016188) | 4.58049782 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.45773232 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 4.42574969 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.28749329 |
| 16 | protein maturation by protein folding (GO:0022417) | 4.25172099 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.24090674 |
| 18 | glutamate secretion (GO:0014047) | 4.22985813 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.22382422 |
| 20 | detection of calcium ion (GO:0005513) | 4.13617481 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 4.10408562 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 4.10408562 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.10408562 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.10408562 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.10408562 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 4.10408562 |
| 27 | type I interferon signaling pathway (GO:0060337) | 3.92970549 |
| 28 | cellular response to type I interferon (GO:0071357) | 3.92970549 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.92112590 |
| 30 | vocalization behavior (GO:0071625) | 3.91265158 |
| 31 | response to peptidoglycan (GO:0032494) | 3.90795918 |
| 32 | response to type I interferon (GO:0034340) | 3.90745106 |
| 33 | COPI coating of Golgi vesicle (GO:0048205) | 3.89977275 |
| 34 | Golgi transport vesicle coating (GO:0048200) | 3.89977275 |
| 35 | neuron cell-cell adhesion (GO:0007158) | 3.79366292 |
| 36 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.75552950 |
| 37 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.68886252 |
| 38 | detection of other organism (GO:0098543) | 3.67109996 |
| 39 | detection of bacterium (GO:0016045) | 3.61557256 |
| 40 | negative regulation of interleukin-12 production (GO:0032695) | 3.61406273 |
| 41 | positive regulation of B cell differentiation (GO:0045579) | 3.60707234 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 3.59955954 |
| 43 | neurotransmitter secretion (GO:0007269) | 3.58944413 |
| 44 | neuromuscular process controlling posture (GO:0050884) | 3.55786887 |
| 45 | locomotory exploration behavior (GO:0035641) | 3.55552924 |
| 46 | B cell mediated immunity (GO:0019724) | 3.54202220 |
| 47 | regulation of vesicle fusion (GO:0031338) | 3.51073677 |
| 48 | regulation of gamma-delta T cell activation (GO:0046643) | 3.48196335 |
| 49 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.47790461 |
| 50 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.46095209 |
| 51 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.45856819 |
| 52 | protein localization to synapse (GO:0035418) | 3.42846829 |
| 53 | B cell receptor signaling pathway (GO:0050853) | 3.42808572 |
| 54 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.41094946 |
| 55 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.40801915 |
| 56 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.40152212 |
| 57 | activation of protein kinase A activity (GO:0034199) | 3.35486682 |
| 58 | synaptic transmission, glutamatergic (GO:0035249) | 3.34551070 |
| 59 | defense response to protozoan (GO:0042832) | 3.32205917 |
| 60 | cellular response to interleukin-15 (GO:0071350) | 3.31804617 |
| 61 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.30349537 |
| 62 | response to interleukin-15 (GO:0070672) | 3.27555427 |
| 63 | startle response (GO:0001964) | 3.27036497 |
| 64 | neuron-neuron synaptic transmission (GO:0007270) | 3.24555685 |
| 65 | mature B cell differentiation involved in immune response (GO:0002313) | 3.24434001 |
| 66 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.24214547 |
| 67 | postsynaptic membrane organization (GO:0001941) | 3.23642661 |
| 68 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.23552779 |
| 69 | leukocyte aggregation (GO:0070486) | 3.21391894 |
| 70 | glutamate receptor signaling pathway (GO:0007215) | 3.21118818 |
| 71 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.20249332 |
| 72 | T cell migration (GO:0072678) | 3.19272158 |
| 73 | insulin secretion (GO:0030073) | 3.18742231 |
| 74 | response to protozoan (GO:0001562) | 3.18473659 |
| 75 | response to host immune response (GO:0052572) | 3.18327061 |
| 76 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.18327061 |
| 77 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.15391344 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 3.14909021 |
| 79 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.14714540 |
| 80 | positive regulation of vesicle fusion (GO:0031340) | 3.14484412 |
| 81 | neutrophil activation (GO:0042119) | 3.13657288 |
| 82 | positive regulation of antigen processing and presentation (GO:0002579) | 3.13486838 |
| 83 | regulation of antigen processing and presentation (GO:0002577) | 3.13235407 |
| 84 | peptide hormone processing (GO:0016486) | 3.12850474 |
| 85 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.12131342 |
| 86 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.08780779 |
| 87 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.08014403 |
| 88 | negative regulation of cation channel activity (GO:2001258) | 3.07613950 |
| 89 | positive regulation of insulin secretion (GO:0032024) | 3.06999465 |
| 90 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.06160677 |
| 91 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.05468500 |
| 92 | negative regulation of T cell mediated immunity (GO:0002710) | 3.04923570 |
| 93 | regulation of B cell apoptotic process (GO:0002902) | 3.03909151 |
| 94 | negative thymic T cell selection (GO:0045060) | 3.03699422 |
| 95 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.03470516 |
| 96 | positive thymic T cell selection (GO:0045059) | 3.03385189 |
| 97 | positive regulation of type 2 immune response (GO:0002830) | 3.02297683 |
| 98 | mature B cell differentiation (GO:0002335) | 3.02050795 |
| 99 | presynaptic membrane assembly (GO:0097105) | 3.01636794 |
| 100 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.01446936 |
| 101 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.00723357 |
| 102 | long-term synaptic potentiation (GO:0060291) | 3.00662860 |
| 103 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.00468111 |
| 104 | detection of external biotic stimulus (GO:0098581) | 2.99947575 |
| 105 | exploration behavior (GO:0035640) | 2.99561923 |
| 106 | regulation of neurotransmitter secretion (GO:0046928) | 2.99276957 |
| 107 | regulation of B cell differentiation (GO:0045577) | 2.98935798 |
| 108 | regulation of insulin secretion (GO:0050796) | 2.98500637 |
| 109 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.97601228 |
| 110 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.97310743 |
| 111 | granulocyte activation (GO:0036230) | 2.96151870 |
| 112 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.95389376 |
| 113 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.95389376 |
| 114 | positive regulation of membrane potential (GO:0045838) | 2.94206841 |
| 115 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.93446130 |
| 116 | neurotransmitter transport (GO:0006836) | 2.93364494 |
| 117 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.93012903 |
| 118 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.92497873 |
| 119 | negative T cell selection (GO:0043383) | 2.92114982 |
| 120 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.91490813 |
| 121 | response to muramyl dipeptide (GO:0032495) | 2.91374160 |
| 122 | protein localization to Golgi apparatus (GO:0034067) | 2.90571945 |
| 123 | innervation (GO:0060384) | 2.90033385 |
| 124 | regulation of mast cell degranulation (GO:0043304) | 2.88699571 |
| 125 | microglial cell activation (GO:0001774) | 2.87479602 |
| 126 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.87462307 |
| 127 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.87320402 |
| 128 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.87052850 |
| 129 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.87052850 |
| 130 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.86690610 |
| 131 | inositol phosphate catabolic process (GO:0071545) | 2.86249876 |
| 132 | NIK/NF-kappaB signaling (GO:0038061) | 2.86052789 |
| 133 | germinal center formation (GO:0002467) | 2.85357428 |
| 134 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.84589666 |
| 135 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.83398573 |
| 136 | mast cell activation (GO:0045576) | 2.83192540 |
| 137 | cellular potassium ion homeostasis (GO:0030007) | 2.81970396 |
| 138 | cellular response to glucagon stimulus (GO:0071377) | 2.80395941 |
| 139 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.79707896 |
| 140 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.79661172 |
| 141 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.79213911 |
| 142 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.78733347 |
| 143 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.77801293 |
| 144 | regulation of interferon-alpha production (GO:0032647) | 2.76377839 |
| 145 | calcium ion-dependent exocytosis (GO:0017156) | 2.75591486 |
| 146 | leukocyte degranulation (GO:0043299) | 2.75567780 |
| 147 | cellular response to interferon-gamma (GO:0071346) | 2.75191341 |
| 148 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.74843193 |
| 149 | response to host (GO:0075136) | 2.74843193 |
| 150 | response to host defenses (GO:0052200) | 2.74843193 |
| 151 | macrophage activation (GO:0042116) | 2.74296521 |
| 152 | regulation of neurotransmitter transport (GO:0051588) | 2.73774775 |
| 153 | synaptic vesicle endocytosis (GO:0048488) | 2.73014282 |
| 154 | regulation of synapse structural plasticity (GO:0051823) | 2.72994509 |
| 155 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.72375637 |
| 156 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.72054999 |
| 157 | cell communication by electrical coupling (GO:0010644) | 2.71291541 |
| 158 | positive regulation of synapse maturation (GO:0090129) | 2.71244009 |
| 159 | transferrin transport (GO:0033572) | 2.69939667 |
| 160 | establishment of synaptic vesicle localization (GO:0097480) | 2.69787735 |
| 161 | synaptic vesicle transport (GO:0048489) | 2.69787735 |
| 162 | positive regulation of interferon-alpha production (GO:0032727) | 2.69767971 |
| 163 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.69626487 |
| 164 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.69202063 |
| 165 | presynaptic membrane organization (GO:0097090) | 2.69163320 |
| 166 | membrane depolarization during action potential (GO:0086010) | 2.68983519 |
| 167 | regulation of peptide hormone secretion (GO:0090276) | 2.68853542 |
| 168 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.67739972 |
| 169 | regulation of synaptic plasticity (GO:0048167) | 2.67629250 |
| 170 | regulation of peptide secretion (GO:0002791) | 2.67361520 |
| 171 | T-helper 1 type immune response (GO:0042088) | 2.67206204 |
| 172 | regulation of beta-amyloid formation (GO:1902003) | 2.67154520 |
| 173 | positive regulation of interleukin-10 production (GO:0032733) | 2.66988817 |
| 174 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.66629658 |
| 175 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.66380110 |
| 176 | positive regulation of interleukin-17 production (GO:0032740) | 2.66199084 |
| 177 | purine nucleotide salvage (GO:0032261) | 2.66023805 |
| 178 | regulation of germinal center formation (GO:0002634) | 2.65368652 |
| 179 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.64462870 |
| 180 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.64271098 |
| 181 | positive regulation of amino acid transport (GO:0051957) | 2.64114418 |
| 182 | detection of molecule of bacterial origin (GO:0032490) | 2.63989895 |
| 183 | signal release (GO:0023061) | 2.63836837 |
| 184 | regulation of postsynaptic membrane potential (GO:0060078) | 2.63726596 |
| 185 | regulation of neurotransmitter levels (GO:0001505) | 2.63457641 |
| 186 | long-term memory (GO:0007616) | 2.62570276 |
| 187 | tolerance induction (GO:0002507) | 2.62085866 |
| 188 | regulation of oxidative phosphorylation (GO:0002082) | 2.61962282 |
| 189 | response to interferon-gamma (GO:0034341) | 2.61780629 |
| 190 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.61652969 |
| 191 | transmission of nerve impulse (GO:0019226) | 2.61640732 |
| 192 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.61372953 |
| 193 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.60329793 |
| 194 | response to interferon-beta (GO:0035456) | 2.59724844 |
| 195 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.59560609 |
| 196 | positive regulation of exocytosis (GO:0045921) | 2.59546271 |
| 197 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.59370614 |
| 198 | negative regulation of heart rate (GO:0010459) | 2.58993169 |
| 199 | regulation of type 2 immune response (GO:0002828) | 2.58615037 |
| 200 | negative regulation of innate immune response (GO:0045824) | 2.56262121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.73749525 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.85675849 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.24312591 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.27323202 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.80558414 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.72544044 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.63704938 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.50139546 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.32610256 |
| 10 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.31201797 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.13346760 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.98703467 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.96034148 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.84509639 |
| 15 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.84446929 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81562031 |
| 17 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.80870040 |
| 18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.76584139 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.68823403 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.68341538 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.66939557 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.62156391 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.62024254 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.56442053 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56215200 |
| 26 | * MYB_26560356_Chip-Seq_TH2_Human | 2.53548922 |
| 27 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.50398010 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.46862171 |
| 29 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.40438252 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.39068185 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38842372 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38809068 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36324013 |
| 34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.34425056 |
| 35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.34425056 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.33703575 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.33279554 |
| 38 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.30560603 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28754681 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.27655781 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.27413519 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.19397197 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.17427928 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.13608746 |
| 45 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.09862135 |
| 46 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07026776 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 2.04890288 |
| 48 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.04654791 |
| 49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.02887540 |
| 50 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.01871186 |
| 51 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.98431175 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.97751922 |
| 53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.96356326 |
| 54 | GATA1_22025678_ChIP-Seq_K562_Human | 1.95572024 |
| 55 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.95514488 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.95226662 |
| 57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.91860749 |
| 58 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.89855205 |
| 59 | * MYB_26560356_Chip-Seq_TH1_Human | 1.86709186 |
| 60 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86316999 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.85896202 |
| 62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.85530135 |
| 63 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.85419085 |
| 64 | UTX_26944678_Chip-Seq_JUKART_Human | 1.84112333 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83375132 |
| 66 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.82418378 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81843123 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.80465295 |
| 69 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80450464 |
| 70 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.79286849 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74791742 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.71101966 |
| 73 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65017665 |
| 74 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64137507 |
| 75 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.62538592 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61465915 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60943377 |
| 78 | VDR_22108803_ChIP-Seq_LS180_Human | 1.59352437 |
| 79 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.58206463 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58120269 |
| 81 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.58027495 |
| 82 | * MAF_26560356_Chip-Seq_TH2_Human | 1.54214047 |
| 83 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51735915 |
| 84 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.50105899 |
| 85 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.48937273 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47504867 |
| 87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.47159988 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46943439 |
| 89 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.46583298 |
| 90 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.44346742 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.42916193 |
| 92 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42892131 |
| 93 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37251739 |
| 94 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35338686 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33761134 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33633065 |
| 97 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.33248701 |
| 98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.32666872 |
| 99 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.32044752 |
| 100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31372130 |
| 101 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30157333 |
| 102 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29854406 |
| 103 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26771404 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26503470 |
| 105 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26239101 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.25440522 |
| 107 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24771090 |
| 108 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22248689 |
| 109 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21857696 |
| 110 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21065356 |
| 111 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19855559 |
| 112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19394820 |
| 113 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19241152 |
| 114 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18933974 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16370508 |
| 116 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16300011 |
| 117 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15379799 |
| 118 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14933763 |
| 119 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14289241 |
| 120 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10832227 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10784303 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10707492 |
| 123 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.10576604 |
| 124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10504293 |
| 125 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10262593 |
| 126 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10056517 |
| 127 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09826300 |
| 128 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09100270 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09070975 |
| 130 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08587045 |
| 131 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.08458730 |
| 132 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08113279 |
| 133 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07994299 |
| 134 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07681111 |
| 135 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06089406 |
| 136 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05218227 |
| 137 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04926304 |
| 138 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04682396 |
| 139 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04495946 |
| 140 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04371181 |
| 141 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03665526 |
| 142 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03561523 |
| 143 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03354825 |
| 144 | * REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03168847 |
| 145 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01947944 |
| 146 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.00908319 |
| 147 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00841821 |
| 148 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00623188 |
| 149 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00545313 |
| 150 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99949971 |
| 151 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99562029 |
| 152 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.99087648 |
| 153 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.99068068 |
| 154 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.98940700 |
| 155 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.98565503 |
| 156 | P300_27268052_Chip-Seq_Bcells_Human | 0.98263659 |
| 157 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.98240844 |
| 158 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97989788 |
| 159 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97160740 |
| 160 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96560880 |
| 161 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.95758300 |
| 162 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95420462 |
| 163 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94640312 |
| 164 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94329465 |
| 165 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94113626 |
| 166 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93415890 |
| 167 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92796482 |
| 168 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91296683 |
| 169 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.91273437 |
| 170 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.89971136 |
| 171 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89831380 |
| 172 | JUN_21703547_ChIP-Seq_K562_Human | 0.89224384 |
| 173 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88586642 |
| 174 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.88497724 |
| 175 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.88035367 |
| 176 | * AR_19668381_ChIP-Seq_PC3_Human | 0.87703573 |
| 177 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87185768 |
| 178 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87087816 |
| 179 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.85760640 |
| 180 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85710381 |
| 181 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85644580 |
| 182 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84364344 |
| 183 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83380065 |
| 184 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82953491 |
| 185 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.81149158 |
| 186 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79258233 |
| 187 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.78912852 |
| 188 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.78327405 |
| 189 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.77572817 |
| 190 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.76751837 |
| 191 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76314548 |
| 192 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76258112 |
| 193 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76169465 |
| 194 | KDM2B_26808549_Chip-Seq_REH_Human | 0.76065821 |
| 195 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.74529906 |
| 196 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.74261369 |
| 197 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.73888922 |
| 198 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.73128434 |
| 199 | GATA3_26560356_Chip-Seq_TH1_Human | 0.71304111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.36711035 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.94277671 |
| 3 | MP0003880_abnormal_central_pattern | 3.86724918 |
| 4 | MP0003724_increased_susceptibility_to | 3.64473513 |
| 5 | MP0003303_peritoneal_inflammation | 3.58933178 |
| 6 | MP0002909_abnormal_adrenal_gland | 3.50606067 |
| 7 | MP0004270_analgesia | 3.38996398 |
| 8 | MP0005671_abnormal_response_to | 3.36261256 |
| 9 | MP0000013_abnormal_adipose_tissue | 3.24647660 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 3.24215861 |
| 11 | MP0003436_decreased_susceptibility_to | 3.23924386 |
| 12 | MP0005000_abnormal_immune_tolerance | 3.07852287 |
| 13 | MP0010386_abnormal_urinary_bladder | 2.95773565 |
| 14 | MP0001800_abnormal_humoral_immune | 2.80501313 |
| 15 | MP0009785_altered_susceptibility_to | 2.80156799 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.75029261 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.69380106 |
| 18 | MP0000685_abnormal_immune_system | 2.66949760 |
| 19 | MP0009745_abnormal_behavioral_response | 2.64604805 |
| 20 | MP0005387_immune_system_phenotype | 2.62597353 |
| 21 | MP0001790_abnormal_immune_system | 2.62597353 |
| 22 | MP0005025_abnormal_response_to | 2.56906114 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.56616137 |
| 24 | MP0002723_abnormal_immune_serum | 2.51152006 |
| 25 | MP0002064_seizures | 2.48883838 |
| 26 | MP0002419_abnormal_innate_immunity | 2.47938376 |
| 27 | MP0002063_abnormal_learning/memory/cond | 2.45297737 |
| 28 | MP0006082_CNS_inflammation | 2.44077114 |
| 29 | MP0002452_abnormal_antigen_presenting | 2.40605247 |
| 30 | MP0002272_abnormal_nervous_system | 2.40307663 |
| 31 | MP0002734_abnormal_mechanical_nocicepti | 2.36955019 |
| 32 | MP0002420_abnormal_adaptive_immunity | 2.36144074 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 2.33621196 |
| 34 | MP0001819_abnormal_immune_cell | 2.33539877 |
| 35 | MP0003763_abnormal_thymus_physiology | 2.31104227 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 2.26126663 |
| 37 | MP0002736_abnormal_nociception_after | 2.23404427 |
| 38 | MP0006276_abnormal_autonomic_nervous | 2.21407363 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 2.16188954 |
| 40 | MP0002735_abnormal_chemical_nociception | 2.10788097 |
| 41 | MP0009046_muscle_twitch | 2.10379654 |
| 42 | MP0002733_abnormal_thermal_nociception | 2.09271405 |
| 43 | MP0003122_maternal_imprinting | 2.05631928 |
| 44 | MP0005646_abnormal_pituitary_gland | 2.03232345 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.97686413 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.97434311 |
| 47 | MP0005379_endocrine/exocrine_gland_phen | 1.95247828 |
| 48 | MP0002398_abnormal_bone_marrow | 1.92521077 |
| 49 | MP0003283_abnormal_digestive_organ | 1.91169294 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.90795183 |
| 51 | MP0001970_abnormal_pain_threshold | 1.89973387 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.89844843 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.89844843 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.89673542 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.88162261 |
| 56 | MP0009278_abnormal_bone_marrow | 1.87541785 |
| 57 | MP0002638_abnormal_pupillary_reflex | 1.83938537 |
| 58 | MP0000716_abnormal_immune_system | 1.82905105 |
| 59 | MP0004043_abnormal_pH_regulation | 1.79273007 |
| 60 | MP0002693_abnormal_pancreas_physiology | 1.77273446 |
| 61 | MP0002067_abnormal_sensory_capabilities | 1.76025810 |
| 62 | MP0001502_abnormal_circadian_rhythm | 1.75375471 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.74275845 |
| 64 | MP0003075_altered_response_to | 1.74045633 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.73632459 |
| 66 | MP0001486_abnormal_startle_reflex | 1.72180302 |
| 67 | MP0002405_respiratory_system_inflammati | 1.71843859 |
| 68 | MP0003300_gastrointestinal_ulcer | 1.70876222 |
| 69 | MP0003172_abnormal_lysosome_physiology | 1.69139276 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.65645580 |
| 71 | MP0004145_abnormal_muscle_electrophysio | 1.65234790 |
| 72 | MP0009764_decreased_sensitivity_to | 1.64528009 |
| 73 | MP0003879_abnormal_hair_cell | 1.64318259 |
| 74 | MP0006072_abnormal_retinal_apoptosis | 1.63996924 |
| 75 | MP0001986_abnormal_taste_sensitivity | 1.63830115 |
| 76 | MP0003329_amyloid_beta_deposits | 1.62629400 |
| 77 | MP0008569_lethality_at_weaning | 1.61198765 |
| 78 | MP0002184_abnormal_innervation | 1.60174009 |
| 79 | MP0001984_abnormal_olfaction | 1.59599037 |
| 80 | MP0001440_abnormal_grooming_behavior | 1.59383470 |
| 81 | MP0000689_abnormal_spleen_morphology | 1.58397514 |
| 82 | MP0004858_abnormal_nervous_system | 1.56070467 |
| 83 | MP0002166_altered_tumor_susceptibility | 1.55164499 |
| 84 | MP0003787_abnormal_imprinting | 1.52480138 |
| 85 | MP0002557_abnormal_social/conspecific_i | 1.51732040 |
| 86 | MP0001944_abnormal_pancreas_morphology | 1.51345743 |
| 87 | MP0009333_abnormal_splenocyte_physiolog | 1.48365150 |
| 88 | MP0005310_abnormal_salivary_gland | 1.48235132 |
| 89 | MP0002722_abnormal_immune_system | 1.47613040 |
| 90 | MP0008469_abnormal_protein_level | 1.47371770 |
| 91 | MP0002429_abnormal_blood_cell | 1.45813963 |
| 92 | MP0005423_abnormal_somatic_nervous | 1.38665052 |
| 93 | MP0004947_skin_inflammation | 1.37537128 |
| 94 | MP0003866_abnormal_defecation | 1.37419013 |
| 95 | MP0001188_hyperpigmentation | 1.36969748 |
| 96 | MP0002132_abnormal_respiratory_system | 1.36278526 |
| 97 | MP0005451_abnormal_body_composition | 1.33507207 |
| 98 | MP0002877_abnormal_melanocyte_morpholog | 1.27297946 |
| 99 | MP0000678_abnormal_parathyroid_gland | 1.25923366 |
| 100 | MP0002822_catalepsy | 1.25392479 |
| 101 | MP0005058_abnormal_lysosome_morphology | 1.24551180 |
| 102 | MP0002396_abnormal_hematopoietic_system | 1.24246697 |
| 103 | MP0000955_abnormal_spinal_cord | 1.22655511 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 1.22111516 |
| 105 | MP0004811_abnormal_neuron_physiology | 1.21754886 |
| 106 | MP0003191_abnormal_cellular_cholesterol | 1.20426782 |
| 107 | MP0002006_tumorigenesis | 1.19199844 |
| 108 | MP0000703_abnormal_thymus_morphology | 1.18863164 |
| 109 | MP0004924_abnormal_behavior | 1.17775632 |
| 110 | MP0005386_behavior/neurological_phenoty | 1.17775632 |
| 111 | MP0001664_abnormal_digestion | 1.17316010 |
| 112 | MP0004510_myositis | 1.15915127 |
| 113 | MP0001905_abnormal_dopamine_level | 1.15340407 |
| 114 | MP0001873_stomach_inflammation | 1.14920257 |
| 115 | MP0004142_abnormal_muscle_tone | 1.13955025 |
| 116 | MP0005075_abnormal_melanosome_morpholog | 1.13663556 |
| 117 | MP0002066_abnormal_motor_capabilities/c | 1.11695085 |
| 118 | MP0005166_decreased_susceptibility_to | 1.11325121 |
| 119 | MP0002234_abnormal_pharynx_morphology | 1.10235356 |
| 120 | MP0001529_abnormal_vocalization | 1.07363681 |
| 121 | MP0000751_myopathy | 1.06609665 |
| 122 | MP0002882_abnormal_neuron_morphology | 1.06387261 |
| 123 | MP0000003_abnormal_adipose_tissue | 1.05909397 |
| 124 | MP0000631_abnormal_neuroendocrine_gland | 1.05847200 |
| 125 | MP0002078_abnormal_glucose_homeostasis | 1.05479074 |
| 126 | MP0003195_calcinosis | 1.03646049 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 1.02801839 |
| 128 | MP0004215_abnormal_myocardial_fiber | 1.02136845 |
| 129 | MP0003633_abnormal_nervous_system | 0.99278615 |
| 130 | MP0002876_abnormal_thyroid_physiology | 0.97967753 |
| 131 | MP0001853_heart_inflammation | 0.96907302 |
| 132 | MP0002163_abnormal_gland_morphology | 0.96197495 |
| 133 | MP0008004_abnormal_stomach_pH | 0.95783585 |
| 134 | MP0005535_abnormal_body_temperature | 0.95161178 |
| 135 | MP0004085_abnormal_heartbeat | 0.94000214 |
| 136 | MP0004808_abnormal_hematopoietic_stem | 0.91803285 |
| 137 | MP0008961_abnormal_basal_metabolism | 0.89886412 |
| 138 | MP0001348_abnormal_lacrimal_gland | 0.89423089 |
| 139 | MP0002069_abnormal_eating/drinking_beha | 0.87366037 |
| 140 | MP0003656_abnormal_erythrocyte_physiolo | 0.87321363 |
| 141 | MP0008874_decreased_physiological_sensi | 0.86266411 |
| 142 | MP0001765_abnormal_ion_homeostasis | 0.86018284 |
| 143 | MP0002277_abnormal_respiratory_mucosa | 0.85504746 |
| 144 | MP0003690_abnormal_glial_cell | 0.83552097 |
| 145 | MP0002229_neurodegeneration | 0.83202608 |
| 146 | MP0002139_abnormal_hepatobiliary_system | 0.80413019 |
| 147 | MP0004036_abnormal_muscle_relaxation | 0.78862691 |
| 148 | MP0000230_abnormal_systemic_arterial | 0.78530041 |
| 149 | MP0001851_eye_inflammation | 0.78140351 |
| 150 | MP0003953_abnormal_hormone_level | 0.78128372 |
| 151 | MP0004233_abnormal_muscle_weight | 0.76779020 |
| 152 | MP0000343_altered_response_to | 0.76607670 |
| 153 | MP0003045_fibrosis | 0.75607106 |
| 154 | MP0006036_abnormal_mitochondrial_physio | 0.75409445 |
| 155 | MP0005551_abnormal_eye_electrophysiolog | 0.73820979 |
| 156 | MP0000778_abnormal_nervous_system | 0.73799458 |
| 157 | MP0002928_abnormal_bile_duct | 0.71898444 |
| 158 | MP0009763_increased_sensitivity_to | 0.71851821 |
| 159 | MP0000858_altered_metastatic_potential | 0.70125717 |
| 160 | MP0003631_nervous_system_phenotype | 0.69986485 |
| 161 | MP0002998_abnormal_bone_remodeling | 0.69913839 |
| 162 | MP0001663_abnormal_digestive_system | 0.68998010 |
| 163 | MP0002152_abnormal_brain_morphology | 0.67104298 |
| 164 | MP0000639_abnormal_adrenal_gland | 0.67045875 |
| 165 | MP0005253_abnormal_eye_physiology | 0.64468422 |
| 166 | MP0005187_abnormal_penis_morphology | 0.64453166 |
| 167 | MP0000613_abnormal_salivary_gland | 0.64092379 |
| 168 | MP0001963_abnormal_hearing_physiology | 0.63005630 |
| 169 | MP0004883_abnormal_blood_vessel | 0.62525474 |
| 170 | MP0003634_abnormal_glial_cell | 0.62489092 |
| 171 | MP0000681_abnormal_thyroid_gland | 0.62477015 |
| 172 | MP0006292_abnormal_olfactory_placode | 0.61875806 |
| 173 | MP0000604_amyloidosis | 0.61843225 |
| 174 | MP0009765_abnormal_xenobiotic_induced | 0.61601406 |
| 175 | MP0004885_abnormal_endolymph | 0.61250281 |
| 176 | MP0001270_distended_abdomen | 0.61005181 |
| 177 | MP0002138_abnormal_hepatobiliary_system | 0.60808287 |
| 178 | MP0002019_abnormal_tumor_incidence | 0.60723057 |
| 179 | MP0002751_abnormal_autonomic_nervous | 0.60026475 |
| 180 | MP0000920_abnormal_myelination | 0.59910224 |
| 181 | MP0005390_skeleton_phenotype | 0.58415889 |
| 182 | MP0002332_abnormal_exercise_endurance | 0.57146560 |
| 183 | MP0008872_abnormal_physiological_respon | 0.56902163 |
| 184 | MP0002009_preneoplasia | 0.55648178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.89297202 |
| 2 | Stomatitis (HP:0010280) | 5.00546055 |
| 3 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.99396311 |
| 4 | Visual hallucinations (HP:0002367) | 4.85105167 |
| 5 | Myositis (HP:0100614) | 4.63513106 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.50541450 |
| 7 | Atonic seizures (HP:0010819) | 4.38030846 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.29410022 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.22271964 |
| 10 | Orchitis (HP:0100796) | 4.17533631 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.06209375 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 3.98375731 |
| 13 | Optic neuritis (HP:0100653) | 3.98375731 |
| 14 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.86746715 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.84062151 |
| 16 | Epileptic encephalopathy (HP:0200134) | 3.77307971 |
| 17 | Myokymia (HP:0002411) | 3.75404319 |
| 18 | Pheochromocytoma (HP:0002666) | 3.72777276 |
| 19 | Meningitis (HP:0001287) | 3.67587473 |
| 20 | Focal seizures (HP:0007359) | 3.61772055 |
| 21 | Obstructive lung disease (HP:0006536) | 3.61204384 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.61204384 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.60124347 |
| 24 | B lymphocytopenia (HP:0010976) | 3.58258532 |
| 25 | Neuroendocrine neoplasm (HP:0100634) | 3.55008486 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.52771371 |
| 27 | Abnormality of B cell number (HP:0010975) | 3.51187508 |
| 28 | Febrile seizures (HP:0002373) | 3.45675561 |
| 29 | Absence seizures (HP:0002121) | 3.39320448 |
| 30 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.36850608 |
| 31 | Vasculitis (HP:0002633) | 3.13920831 |
| 32 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.11066296 |
| 33 | Agammaglobulinemia (HP:0004432) | 3.10809163 |
| 34 | Acute necrotizing encephalopathy (HP:0006965) | 3.07267213 |
| 35 | Recurrent viral infections (HP:0004429) | 3.05394341 |
| 36 | Symptomatic seizures (HP:0011145) | 3.04681163 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 3.03408151 |
| 38 | Menstrual irregularities (HP:0000858) | 3.00567790 |
| 39 | Dialeptic seizures (HP:0011146) | 2.99618789 |
| 40 | Retinal dysplasia (HP:0007973) | 2.99610472 |
| 41 | Type II lissencephaly (HP:0007260) | 2.97861499 |
| 42 | Anxiety (HP:0000739) | 2.95791150 |
| 43 | Increased IgM level (HP:0003496) | 2.95540845 |
| 44 | Agitation (HP:0000713) | 2.94028631 |
| 45 | Panhypogammaglobulinemia (HP:0003139) | 2.92352779 |
| 46 | Encephalitis (HP:0002383) | 2.90482601 |
| 47 | Cellulitis (HP:0100658) | 2.89600733 |
| 48 | Recurrent skin infections (HP:0001581) | 2.89574038 |
| 49 | Episodic fever (HP:0001954) | 2.87316325 |
| 50 | Hypoglycemic seizures (HP:0002173) | 2.87145468 |
| 51 | Increased IgE level (HP:0003212) | 2.86948453 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.85537649 |
| 53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.85101426 |
| 54 | T lymphocytopenia (HP:0005403) | 2.83730596 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.81225062 |
| 56 | Hypothermia (HP:0002045) | 2.81100643 |
| 57 | Severe combined immunodeficiency (HP:0004430) | 2.78976210 |
| 58 | Leukocytosis (HP:0001974) | 2.76017639 |
| 59 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.74181788 |
| 60 | Recurrent cutaneous fungal infections (HP:0011370) | 2.74181788 |
| 61 | Generalized tonic-clonic seizures (HP:0002069) | 2.74040063 |
| 62 | Petechiae (HP:0000967) | 2.73938785 |
| 63 | Progressive cerebellar ataxia (HP:0002073) | 2.73371399 |
| 64 | Hyperventilation (HP:0002883) | 2.71945064 |
| 65 | Abnormality of T cell number (HP:0011839) | 2.70573975 |
| 66 | Pulmonary infiltrates (HP:0002113) | 2.69513630 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.69430392 |
| 68 | Granulocytopenia (HP:0001913) | 2.65050118 |
| 69 | Prolonged bleeding time (HP:0003010) | 2.63199612 |
| 70 | Blue irides (HP:0000635) | 2.61831626 |
| 71 | Urticaria (HP:0001025) | 2.60527726 |
| 72 | Epileptiform EEG discharges (HP:0011182) | 2.60032214 |
| 73 | Depression (HP:0000716) | 2.59170911 |
| 74 | Progressive macrocephaly (HP:0004481) | 2.57759005 |
| 75 | Chest pain (HP:0100749) | 2.55322316 |
| 76 | Keratoconjunctivitis (HP:0001096) | 2.55302926 |
| 77 | Abnormality of T cells (HP:0002843) | 2.55264961 |
| 78 | Truncal ataxia (HP:0002078) | 2.54589394 |
| 79 | EEG with generalized epileptiform discharges (HP:0011198) | 2.51126149 |
| 80 | IgG deficiency (HP:0004315) | 2.50337459 |
| 81 | Decreased circulating renin level (HP:0003351) | 2.49432333 |
| 82 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.48553780 |
| 83 | Abnormality of glycolipid metabolism (HP:0010969) | 2.48553780 |
| 84 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.48553780 |
| 85 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.47598712 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 2.45203652 |
| 87 | Spinal canal stenosis (HP:0003416) | 2.41700731 |
| 88 | Mitochondrial inheritance (HP:0001427) | 2.39908530 |
| 89 | Ankle clonus (HP:0011448) | 2.39335620 |
| 90 | Arterial thrombosis (HP:0004420) | 2.38728490 |
| 91 | Loss of speech (HP:0002371) | 2.38255858 |
| 92 | Hemoptysis (HP:0002105) | 2.38173649 |
| 93 | Gingivitis (HP:0000230) | 2.37412582 |
| 94 | Eosinophilia (HP:0001880) | 2.37384756 |
| 95 | Dysostosis multiplex (HP:0000943) | 2.36466096 |
| 96 | Increased cerebral lipofuscin (HP:0011813) | 2.36149734 |
| 97 | Ketoacidosis (HP:0001993) | 2.35423916 |
| 98 | Acute hepatic failure (HP:0006554) | 2.34853410 |
| 99 | Hypsarrhythmia (HP:0002521) | 2.34401034 |
| 100 | Supranuclear gaze palsy (HP:0000605) | 2.34195058 |
| 101 | Hyperparathyroidism (HP:0000843) | 2.31392160 |
| 102 | Action tremor (HP:0002345) | 2.30365055 |
| 103 | Hypercortisolism (HP:0001578) | 2.29742284 |
| 104 | Hemiparesis (HP:0001269) | 2.29642557 |
| 105 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.29066569 |
| 106 | Gastrointestinal inflammation (HP:0004386) | 2.28055847 |
| 107 | Medial flaring of the eyebrow (HP:0010747) | 2.25290382 |
| 108 | Autoimmune thrombocytopenia (HP:0001973) | 2.23936936 |
| 109 | Epistaxis (HP:0000421) | 2.23606425 |
| 110 | Combined immunodeficiency (HP:0005387) | 2.23223298 |
| 111 | Sepsis (HP:0100806) | 2.22688257 |
| 112 | Inflammation of the large intestine (HP:0002037) | 2.22500954 |
| 113 | Acute encephalopathy (HP:0006846) | 2.22169091 |
| 114 | Thyroiditis (HP:0100646) | 2.22069804 |
| 115 | Pulmonary embolism (HP:0002204) | 2.21349593 |
| 116 | Dysautonomia (HP:0002459) | 2.20099834 |
| 117 | Recurrent bronchitis (HP:0002837) | 2.19404275 |
| 118 | Gait imbalance (HP:0002141) | 2.14070834 |
| 119 | Osteomyelitis (HP:0002754) | 2.13266281 |
| 120 | Progressive inability to walk (HP:0002505) | 2.11592555 |
| 121 | Abnormality of T cell physiology (HP:0011840) | 2.11156807 |
| 122 | Joint swelling (HP:0001386) | 2.10958417 |
| 123 | Spontaneous hematomas (HP:0007420) | 2.09805491 |
| 124 | Limb dystonia (HP:0002451) | 2.09007820 |
| 125 | Lymphopenia (HP:0001888) | 2.08437015 |
| 126 | Poor suck (HP:0002033) | 2.07158290 |
| 127 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.06552704 |
| 128 | Abnormality of eosinophils (HP:0001879) | 2.06551399 |
| 129 | Abnormality of the pleura (HP:0002103) | 2.06410397 |
| 130 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05385436 |
| 131 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05385436 |
| 132 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05385436 |
| 133 | Thrombocytosis (HP:0001894) | 2.04935855 |
| 134 | Gastrointestinal stroma tumor (HP:0100723) | 2.04247551 |
| 135 | Congenital primary aphakia (HP:0007707) | 2.03878708 |
| 136 | Purpura (HP:0000979) | 2.02424099 |
| 137 | Hypertensive crisis (HP:0100735) | 2.01244555 |
| 138 | Nephrogenic diabetes insipidus (HP:0009806) | 2.00987967 |
| 139 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00955229 |
| 140 | Mucopolysacchariduria (HP:0008155) | 2.00955229 |
| 141 | Increased CSF lactate (HP:0002490) | 1.98955337 |
| 142 | Gingival bleeding (HP:0000225) | 1.98065465 |
| 143 | Anorexia (HP:0002039) | 1.97946586 |
| 144 | Vertigo (HP:0002321) | 1.96742254 |
| 145 | Verrucae (HP:0200043) | 1.96060030 |
| 146 | Papilloma (HP:0012740) | 1.96060030 |
| 147 | Fatigue (HP:0012378) | 1.95829052 |
| 148 | Abnormal eating behavior (HP:0100738) | 1.95759654 |
| 149 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.95502989 |
| 150 | Cortical visual impairment (HP:0100704) | 1.95101941 |
| 151 | Hydroureter (HP:0000072) | 1.94887094 |
| 152 | Chronic diarrhea (HP:0002028) | 1.94726865 |
| 153 | Gangrene (HP:0100758) | 1.94504557 |
| 154 | Scanning speech (HP:0002168) | 1.94340330 |
| 155 | Acne (HP:0001061) | 1.94240001 |
| 156 | Psychosis (HP:0000709) | 1.93257430 |
| 157 | Megalencephaly (HP:0001355) | 1.92305822 |
| 158 | Amblyopia (HP:0000646) | 1.91384211 |
| 159 | Growth hormone excess (HP:0000845) | 1.91157883 |
| 160 | Broad-based gait (HP:0002136) | 1.91097878 |
| 161 | Recurrent pneumonia (HP:0006532) | 1.90647748 |
| 162 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.90070259 |
| 163 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.90070259 |
| 164 | Hepatoblastoma (HP:0002884) | 1.89203006 |
| 165 | Oligomenorrhea (HP:0000876) | 1.88627957 |
| 166 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.87223092 |
| 167 | Hypoventilation (HP:0002791) | 1.87222187 |
| 168 | Neoplasm of the adrenal gland (HP:0100631) | 1.86870812 |
| 169 | Hypokalemia (HP:0002900) | 1.86613203 |
| 170 | Impaired smooth pursuit (HP:0007772) | 1.85622243 |
| 171 | Hypoglycemic coma (HP:0001325) | 1.83743035 |
| 172 | Late onset (HP:0003584) | 1.83100295 |
| 173 | Adrenal overactivity (HP:0002717) | 1.82901241 |
| 174 | Failure to thrive in infancy (HP:0001531) | 1.82499484 |
| 175 | Drooling (HP:0002307) | 1.79061320 |
| 176 | Excessive salivation (HP:0003781) | 1.79061320 |
| 177 | Gaze-evoked nystagmus (HP:0000640) | 1.78983594 |
| 178 | Hepatocellular necrosis (HP:0001404) | 1.78851856 |
| 179 | Osteomalacia (HP:0002749) | 1.78374771 |
| 180 | Abnormality of the fovea (HP:0000493) | 1.77917700 |
| 181 | Papilledema (HP:0001085) | 1.77457042 |
| 182 | Progressive neurologic deterioration (HP:0002344) | 1.76369204 |
| 183 | Poor eye contact (HP:0000817) | 1.75842813 |
| 184 | Dysmetria (HP:0001310) | 1.75099506 |
| 185 | Bradykinesia (HP:0002067) | 1.73948251 |
| 186 | Atelectasis (HP:0100750) | 1.72485146 |
| 187 | Delusions (HP:0000746) | 1.72018939 |
| 188 | Abnormality of alanine metabolism (HP:0010916) | 1.71511638 |
| 189 | Hyperalaninemia (HP:0003348) | 1.71511638 |
| 190 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.71511638 |
| 191 | Myotonia (HP:0002486) | 1.70464050 |
| 192 | Restlessness (HP:0000711) | 1.70064587 |
| 193 | Diplopia (HP:0000651) | 1.69385392 |
| 194 | Abnormality of binocular vision (HP:0011514) | 1.69385392 |
| 195 | Dysdiadochokinesis (HP:0002075) | 1.68834965 |
| 196 | Hepatic necrosis (HP:0002605) | 1.68554412 |
| 197 | Muscular hypotonia of the trunk (HP:0008936) | 1.68536130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.77643625 |
| 2 | MAP4K1 | 3.87360575 |
| 3 | MAP3K12 | 3.34186374 |
| 4 | MAP2K7 | 2.90766535 |
| 5 | CASK | 2.65165218 |
| 6 | MAPK15 | 2.59815326 |
| 7 | MAP2K3 | 2.58215482 |
| 8 | EPHA4 | 2.55959259 |
| 9 | TYK2 | 2.52802790 |
| 10 | TAOK3 | 2.45733558 |
| 11 | MAP3K14 | 2.45682317 |
| 12 | NTRK1 | 2.44024431 |
| 13 | KIT | 2.41388750 |
| 14 | CAMKK2 | 2.40081492 |
| 15 | MAP3K4 | 2.38984647 |
| 16 | TXK | 2.37550095 |
| 17 | INSRR | 2.35441980 |
| 18 | PRKD3 | 2.33008548 |
| 19 | BCKDK | 2.31765456 |
| 20 | MAP3K9 | 2.28033391 |
| 21 | MAP3K11 | 2.17202229 |
| 22 | ERN1 | 2.15464833 |
| 23 | NME2 | 2.14721667 |
| 24 | JAK3 | 2.12023788 |
| 25 | SYK | 2.06283747 |
| 26 | MINK1 | 2.05121128 |
| 27 | GRK6 | 2.00026612 |
| 28 | WNK3 | 1.95446516 |
| 29 | TBK1 | 1.95100629 |
| 30 | BLK | 1.94321982 |
| 31 | IRAK4 | 1.93338373 |
| 32 | ARAF | 1.93109699 |
| 33 | IKBKE | 1.89727486 |
| 34 | KSR2 | 1.84565614 |
| 35 | MAP3K2 | 1.75204067 |
| 36 | MAP3K1 | 1.73616558 |
| 37 | CDK19 | 1.72652725 |
| 38 | DAPK2 | 1.71864639 |
| 39 | PASK | 1.63063972 |
| 40 | CSK | 1.61900330 |
| 41 | GRK5 | 1.59731476 |
| 42 | MAP2K4 | 1.56885584 |
| 43 | BTK | 1.53925467 |
| 44 | IKBKB | 1.52509638 |
| 45 | MATK | 1.48697050 |
| 46 | DAPK1 | 1.48592177 |
| 47 | FLT3 | 1.48333460 |
| 48 | JAK1 | 1.44909221 |
| 49 | HIPK2 | 1.41624307 |
| 50 | RIPK4 | 1.40826012 |
| 51 | ZAP70 | 1.38779388 |
| 52 | CSF1R | 1.35496955 |
| 53 | IRAK3 | 1.35223377 |
| 54 | LYN | 1.33101732 |
| 55 | TNIK | 1.32338421 |
| 56 | UHMK1 | 1.28206903 |
| 57 | PLK2 | 1.27394118 |
| 58 | CDK5 | 1.24088994 |
| 59 | SCYL2 | 1.23256269 |
| 60 | HCK | 1.22146637 |
| 61 | PINK1 | 1.22009559 |
| 62 | WNK4 | 1.21126745 |
| 63 | PAK6 | 1.19810293 |
| 64 | TAOK2 | 1.19574681 |
| 65 | PIK3CG | 1.17880521 |
| 66 | MAP2K6 | 1.17661502 |
| 67 | CAMKK1 | 1.17515442 |
| 68 | TAOK1 | 1.17456910 |
| 69 | MAP3K3 | 1.15218209 |
| 70 | MUSK | 1.15034267 |
| 71 | LCK | 1.10273118 |
| 72 | MAPK13 | 1.09212151 |
| 73 | BMPR2 | 1.07730087 |
| 74 | PRKCG | 1.05896743 |
| 75 | JAK2 | 1.05052871 |
| 76 | PAK3 | 1.03147817 |
| 77 | NME1 | 1.01089356 |
| 78 | TEC | 1.00366995 |
| 79 | TESK2 | 0.98268991 |
| 80 | BRAF | 0.97441631 |
| 81 | PRKCH | 0.94607178 |
| 82 | NTRK2 | 0.93980515 |
| 83 | KSR1 | 0.93351610 |
| 84 | MARK1 | 0.93191002 |
| 85 | CAMK2A | 0.92380411 |
| 86 | ITK | 0.88733282 |
| 87 | PNCK | 0.88198252 |
| 88 | GRK7 | 0.87939820 |
| 89 | CAMK2D | 0.87635039 |
| 90 | PRKCQ | 0.87148008 |
| 91 | CAMK2B | 0.87102057 |
| 92 | PHKG1 | 0.86718302 |
| 93 | PHKG2 | 0.86718302 |
| 94 | STK16 | 0.85399033 |
| 95 | FER | 0.85253566 |
| 96 | FRK | 0.85223278 |
| 97 | ADRBK2 | 0.84711581 |
| 98 | IRAK1 | 0.84359145 |
| 99 | PRKCE | 0.80996678 |
| 100 | SIK2 | 0.80397769 |
| 101 | PDK1 | 0.79128510 |
| 102 | LMTK2 | 0.78926404 |
| 103 | CAMK1 | 0.78268782 |
| 104 | FES | 0.78210845 |
| 105 | PRPF4B | 0.78039724 |
| 106 | RET | 0.77686617 |
| 107 | SIK3 | 0.77205563 |
| 108 | RAF1 | 0.75987802 |
| 109 | TRPM7 | 0.71346469 |
| 110 | CCNB1 | 0.69398542 |
| 111 | FGR | 0.69303337 |
| 112 | MAPK7 | 0.68548304 |
| 113 | CSNK1G2 | 0.68203816 |
| 114 | AKT3 | 0.67916871 |
| 115 | SGK494 | 0.66929767 |
| 116 | SGK223 | 0.66929767 |
| 117 | CDC42BPA | 0.66434519 |
| 118 | PTK2B | 0.65921883 |
| 119 | PRKD2 | 0.61997889 |
| 120 | FGFR3 | 0.60663030 |
| 121 | CAMK2G | 0.60508531 |
| 122 | SGK2 | 0.60308234 |
| 123 | MYLK | 0.59099784 |
| 124 | MAP3K13 | 0.57378656 |
| 125 | DYRK1A | 0.57284721 |
| 126 | CDK14 | 0.56542310 |
| 127 | NLK | 0.56354799 |
| 128 | MAPK12 | 0.56285837 |
| 129 | MAP2K1 | 0.56203384 |
| 130 | PDPK1 | 0.55196764 |
| 131 | MAPK11 | 0.53896763 |
| 132 | MAP3K5 | 0.53624584 |
| 133 | ICK | 0.53268495 |
| 134 | LIMK1 | 0.51424450 |
| 135 | PRKACA | 0.49570633 |
| 136 | WNK1 | 0.48980152 |
| 137 | KDR | 0.48715176 |
| 138 | ADRBK1 | 0.48565619 |
| 139 | PIM1 | 0.47149421 |
| 140 | TNK2 | 0.44298237 |
| 141 | STK38 | 0.41424785 |
| 142 | MARK3 | 0.41172589 |
| 143 | CSNK1G3 | 0.40211765 |
| 144 | EPHA3 | 0.40062463 |
| 145 | FYN | 0.39316224 |
| 146 | VRK2 | 0.38990905 |
| 147 | CSNK1A1 | 0.38838079 |
| 148 | SGK1 | 0.38815722 |
| 149 | PRKCD | 0.38388412 |
| 150 | CDK18 | 0.38092277 |
| 151 | PIM2 | 0.37857486 |
| 152 | PRKG2 | 0.36528083 |
| 153 | MAP2K2 | 0.33577573 |
| 154 | BCR | 0.32505799 |
| 155 | CDK15 | 0.32426758 |
| 156 | EPHB1 | 0.31829305 |
| 157 | TESK1 | 0.31211533 |
| 158 | CDK11A | 0.30473891 |
| 159 | MAPKAPK5 | 0.30128663 |
| 160 | PTK2 | 0.29682127 |
| 161 | CSNK1A1L | 0.29123209 |
| 162 | IRAK2 | 0.29094781 |
| 163 | ALK | 0.28993451 |
| 164 | STK11 | 0.28979395 |
| 165 | SMG1 | 0.27062918 |
| 166 | CHUK | 0.26193691 |
| 167 | RPS6KL1 | 0.25591256 |
| 168 | RPS6KC1 | 0.25591256 |
| 169 | MAPK4 | 0.25475708 |
| 170 | ABL1 | 0.24757282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.66284752 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.25291472 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.22615613 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 3.19309125 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.14394178 |
| 6 | Asthma_Homo sapiens_hsa05310 | 3.03501972 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.00332188 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.99471987 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.98616225 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.95703428 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.87544732 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.58660684 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 2.45401700 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 2.45210219 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.44266430 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.43628769 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 2.41936282 |
| 18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.38880431 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.34436394 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.31631762 |
| 21 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.19387448 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 2.18462199 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.15755123 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 2.13316689 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.13223321 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.10776780 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.10345020 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.07488624 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.06651162 |
| 30 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.03345765 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.95965654 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.95766290 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92318137 |
| 34 | Cocaine addiction_Homo sapiens_hsa05030 | 1.92194646 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.84576523 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.84424339 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82252382 |
| 38 | Olfactory transduction_Homo sapiens_hsa04740 | 1.75219021 |
| 39 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.72982052 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.70990833 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.67613144 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.66413785 |
| 43 | Parkinsons disease_Homo sapiens_hsa05012 | 1.66258610 |
| 44 | Salivary secretion_Homo sapiens_hsa04970 | 1.66220934 |
| 45 | Alzheimers disease_Homo sapiens_hsa05010 | 1.64586087 |
| 46 | Measles_Homo sapiens_hsa05162 | 1.62287137 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.62256873 |
| 48 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.57591404 |
| 49 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.56427751 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.55035905 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51110956 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.47549931 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 1.44800120 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44702624 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.42890670 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.39159609 |
| 57 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.37822434 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35714541 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.33950656 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.32890095 |
| 61 | Long-term depression_Homo sapiens_hsa04730 | 1.32458841 |
| 62 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.32007303 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 1.30432777 |
| 64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22559343 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.21067214 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18321232 |
| 67 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.18076307 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17824220 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.17502923 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15772685 |
| 71 | Malaria_Homo sapiens_hsa05144 | 1.15199682 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.14709184 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14270111 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12574088 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12452511 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12245211 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.11227861 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 1.07856362 |
| 79 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07812633 |
| 80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04906263 |
| 81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03483579 |
| 82 | Gap junction_Homo sapiens_hsa04540 | 1.03374877 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 1.00750107 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00136326 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.96623738 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96552362 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.92818605 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91699737 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91467030 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.89457103 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.89190886 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88336846 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87450268 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87090185 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84622154 |
| 96 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83667866 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83297281 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82650392 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.82453174 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82421386 |
| 101 | Alcoholism_Homo sapiens_hsa05034 | 0.82058843 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81699823 |
| 103 | Salmonella infection_Homo sapiens_hsa05132 | 0.80739006 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80274274 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80190059 |
| 106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76549143 |
| 107 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.75443708 |
| 108 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75221020 |
| 109 | Hepatitis B_Homo sapiens_hsa05161 | 0.74631344 |
| 110 | Melanogenesis_Homo sapiens_hsa04916 | 0.72905424 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69602238 |
| 112 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69232307 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.68652043 |
| 114 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67544008 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67250358 |
| 116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63877357 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63313020 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63306748 |
| 119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62094503 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59983185 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59182399 |
| 122 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58515483 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58040678 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56816716 |
| 125 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56792757 |
| 126 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56652995 |
| 127 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52214967 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52052106 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51610502 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51477815 |
| 131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48412750 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.48351450 |
| 133 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.48234220 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46314592 |
| 135 | Phototransduction_Homo sapiens_hsa04744 | 0.42690274 |
| 136 | Apoptosis_Homo sapiens_hsa04210 | 0.42404786 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42347866 |
| 138 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41288542 |
| 139 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40237735 |
| 140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38933099 |
| 141 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.38224282 |
| 142 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38080448 |
| 143 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35749698 |
| 144 | Lysosome_Homo sapiens_hsa04142 | 0.35716220 |
| 145 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34730328 |
| 146 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33187016 |
| 147 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31330439 |
| 148 | Insulin resistance_Homo sapiens_hsa04931 | 0.30753079 |
| 149 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30162263 |
| 150 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29703398 |
| 151 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.28624204 |
| 152 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.28541123 |
| 153 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.26555732 |
| 154 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25210646 |
| 155 | Axon guidance_Homo sapiens_hsa04360 | 0.24636968 |
| 156 | Phagosome_Homo sapiens_hsa04145 | 0.24106229 |
| 157 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.23898351 |
| 158 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23144236 |
| 159 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.22008990 |
| 160 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21437573 |
| 161 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20417850 |
| 162 | Endocytosis_Homo sapiens_hsa04144 | 0.19880703 |
| 163 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.18116702 |
| 164 | Peroxisome_Homo sapiens_hsa04146 | 0.17582434 |
| 165 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17503407 |

